Watch Now: Webinar on Ultrasound Blood-Brain Barrier Disruption in Neuro-Oncology

Published:

Register now…
                

Webinar on Ultrasound Blood-Brain Barrier Disruption in Neuro-Oncology


Click to enlarge >

On October 13, 2020, the Focused Ultrasound Foundation and the Society for Neuro-Oncology (SNO) hosted a webinar on ultrasound-mediated blood-brain barrier disruption (BBBD). 

Multiple clinical trials are ongoing or planned to investigate this rapidly developing approach to enhance small molecule, antibody, and cell delivery to brain tumors. This webinar brough togbether the pharmaceutical and biotech companies that are advancing this technology with investigators to provide an update on opportunities and challenges for using ultrasound BBBD to deliver therapeutics to brain tumor patients.

Five brief presentations by experts across the field were followed by a Q&A discussion.

WATCH THE RECORDING >


ONLINE WEBINAR
Ultrasound Blood-Brain Barrier Disruption in Neuro-Oncology

Tuesday, October 13, 2020
11:00 AM Eastern

WATCH NOW >


Moderators

Gelareh Zadeh, MD, PhD
President, Society for Neuro-Oncology 
Suzanne LeBlang, MD
Director of Clinical Relationships, Focused Ultrasound Foundation 

Panelists & Topics

Overview on the Use of Ultrasound for the Treatment of Glioma
John de Groot, MD
Professor, University of Texas MD Anderson Cancer Center
Focused Ultrasound Modulation of the Blood-Brain Barrier: Basic Principles and Technological Advances
Kullervo Hynynen, MSc, PhD
Senior Scientist, Sunnybrook Health Sciences Centre
Transcranial MR-Guided Focused Ultrasound in Neuro-Oncology: Proof-of-Concept and Experience in Early Phase Human Trials
Nir Lipsman, MD, PhD, FRCSC
Neurosurgeon and Scientist, Sunnybrook Health Sciences Centre
Clinical Effectiveness of Targeted and Transient Blood-Brain Barrier Opening via Neuronavigation-Guided Focused Ultrasound for Brain Tumors
Kuo-Chen Wei, MD
Neurosurgeon and Scientist, Chang Gung Memorial Hospital
The Use of Skull Implantable Ultrasound for Delivery of Paclitaxel for Glioblastoma
Adam Sonabend, MD
Assistant Professor of Neurological Surgery, Northwestern University, Feinberg School of Medicine

See the Full Program >